Piramal Pharma Ltd.
PPLPHARMA Share PricePharmaceuticals & Drugs
₹180.85
-1.2 (-0.7%)
As on December 4, 2025
Exchange Scrips: BSE543635NSEPPLPHARMAISININE0DK501011
Market Cap ₹ 23,845 Cr
P/E Ratio 262.83
Dividend Yield 0.01 %
Performance
Market performance
Open182.48
High182.5
Volumes43,07,960
Prev180.85
Low179.6
As on2025-12-04
Historical performance
1 Year High279.25
3 Year High307.9
5 Year High307.9
1 Year Low179.6
3 Year Low61.62
5 Year Low61.62
Fundamentals
Company Valuation
Market Cap (₹Cr)
23,845
Face Value (₹)
10
P/E Ratio
262.83
Dividend Yield
0.01 %
Investment Returns
1 Year
-31.7%
3 Years
31.5%
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 184.05 | Bearish |
| 10-DMA | 185.36 | Bearish |
| 20-DMA | 189.6 | Bearish |
| 50-DMA | 194.44 | Bearish |
| 100-DMA | 196.48 | Bearish |
| 200-DMA | 202.3 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 17 | 17 | 17 | 17 | 17 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 17 | 17 | 17 | 17 | 17 |
| Public Investors | 462494 | 458413 | 432826 | 418425 | 359734 |
| Government | 3 | 3 | 3 | 2 | 1 |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 262.83.
- 3Y Stock Price CAGR of the stock is 9.2.
- The stock has a beta of 1.0.
- In the last financial year, the company had an EBITDA of ₹15796 Million.
- The company generated revenue of ₹91512 Million in the previous financial year.
Piramal Pharma Ltd.
180.85-1.2 (-0.7%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 659675.4
No. of Shares: 3648 (Approx)
Performance:-34%
P/L: ₹-340324.6
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
